文献速递胸部肿瘤放疗放疗物理与技术

非小细胞肺癌放疗中及放疗后镓-68通气灌注PET/CT的前瞻性研究

A prospective study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancer.
PubMed 文献 · Radiother Oncol · 2025-10-16

该前瞻性非随机观察性临床试验纳入67例接受根治性放疗±化疗的非小细胞肺癌患者,在基线、治疗中及治疗后3、12个月行68Ga 4D V/Q PET/CT,评估放疗剂量对肺通气灌注的影响及与临床结局的关联。结果显示从基线至治疗后3个月肺通气和灌注及FEV1、DLCO轻度下降,≥2级肺炎发生20例(32%),且30%阈值下灌注肺V54 Gy较高与≥2级肺炎相关。

要点

  • 67例NSCLC根治性放疗患者中≥2级肺炎发生率为32%。
  • 30%阈值下灌注肺V54 Gy较高与≥2级肺炎相关(p=0.003)。
  • 通气或灌注肺绝对变化与≥2级肺炎无关联。

核心结论

  • 从基线至放疗后3个月,68Ga 4D V/Q PET/CT显示肺通气和灌注下降。
  • 受照近治疗剂量的灌注良好肺体积与≥2级肺炎发生相关,值得未来研究。

研究设计与样本

  • 前瞻性非随机观察性临床试验,纳入67例接受根治性放疗±化疗的NSCLC患者。
  • 在基线、治疗中及治疗后3、12个月行68Ga 4D V/Q PET/CT,基线和治疗后每3个月评估肺功能与毒性。

主要发现

  • 67例可评估,44例(66%)为男性,平均年龄68岁,61例(91%)ECOG 0-1。
  • 从基线至治疗后3个月肺通气灌注及FEV1、DLCO轻度下降。
  • 30%阈值下灌注肺V54 Gy在≥2级肺炎者中更高(中位12.9% vs 6.3%,p=0.003)。
  • 通气(p=0.12)或灌注(p=0.14)肺绝对变化与≥2级肺炎无关联。

关键数值与推荐

  • 采用68Ga 4D V/Q PET/CT定义的通气和灌注肺5%、30%、70%阈值评估剂量体积与毒性关联。
  • ≥2级肺炎者30%阈值下灌注肺V54 Gy中位12.9%(IQR 8.7-14.8%),无≥2级肺炎者为6.3%(IQR 3.7-8.5%),p=0.003。

临床怎么用

  • 可考虑利用68Ga 4D V/Q PET/CT评估灌注肺的剂量分布以辅助预测≥2级肺炎风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To utilize 68Gallium (Ga) Ventilation-Perfusion (V/Q) 4-dimensional (4D) PET/CT to establish the impact of curative radiotherapy (RT) doses on lung ventilation and perfusion, and to evaluate associations with clinical outcomes. METHODS AND MATERIALS: This prospective non-randomized observational clinical trial included 67 patients undergoing definitive RT +/-chemotherapy for NSCLC. Patients underwent 68Ga 4D V/Q PET/CT at baseline, mid-treatment, and at 3- and 12-months post-treatment. Pulmonary Function Tests (PFTs) and toxicities were assessed at baseline and 3 monthly after treatment. Linear mixed models were used to assess for associations between radiotherapy dose-volume, applied to ventilated and perfused lung at 5 %, 30 % and 70 % thresholds as defined by 68Ga 4D V/Q PET/CT, and toxicity. RESULTS: Sixty-seven patients were evaluable, of whom 44 (66 %) were male, mean age was 68, and 61 (91 %) were ECOG 0-1. Sixty-three patients completed treatment and grade ≥2 pneumonitis occurred in 20 (32 %). Lung ventilation and perfusion, and FEV1 and DLCO, fell slightly from baseline to 3-months post treatment. V54 Gy of perfused lung at the 30 % threshold was higher in those with grade ≥2 pneumonitis (median 12.9 % (IQR 8.7-14.8 %) vs 6.3 % (IQR 3.7-8.5 %), p = 0.003). No association between grade ≥2 pneumonitis and the absolute change in ventilated (p = 0.12) or perfused (p = 0.14) lung was observed. CONCLUSIONS: We observed a decrease in lung ventilation and perfusion on 68Ga 4D V/Q PET/CT from baseline to 3 months after RT. The association between the volume of well-perfused lung receiving near-therapeutic RT doses and the development of grade ≥2 pneumonitis warrants future investigation.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Wallace ND, Bressel M, Hardcastle N, et al. A prospective study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancer. Radiother Oncol. 2025. PMID: 41075984. doi:10.1016/j.radonc.2025.111179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。